CTI BioPharma logo CTI BioPharma Corp (NASDAQ:CTIC) insider Value Fund L. P. Biotechnology purchased 6,333,333 shares of the firm’s stock in a transaction dated Friday, February 9th. The stock was acquired at an average cost of $3.00 per share, for a total transaction of $18,999,999.00.
0 Comments